Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-Putty vs Formocresol for Vital Pulpotomy in Primary Molars
NCT06288477Recruiting
- Sponsor
- October University for Modern Sciences and Arts
- Start
- Mar 2024
- Primary completion
- May 2024
- Modality
- Implantable Devices
- Countries
- 1
01
Overview
Randomised, double-blind trial of NeoPUTTY MTA in dental caries and pulpitis (2 arms), sponsored by October University for Modern Sciences and Arts. Primary endpoint: Clinical and Radiographic Success at 12 months. Started Mar 2024; status: recruiting.
02
Drugs
NeoPUTTY MTA
03
Conditions
dental cariespulpitis
Beyond the preview
Go deeper on NCT06288477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06288477.